Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.

MLA

van Agthoven, M., et al. “Cost Analysis and Quality of Life Assessment Comparing Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation or Autologous Bone Marrow Transplantation for Refractory or Relapsed Non-Hodgkin’s Lymphoma or Hodgkin’s Disease. a Prospective Randomised Trial.” European Journal of Cancer (Oxford, England : 1990), vol. 37, no. 14, Sept. 2001, pp. 1781–89. EBSCOhost, https://doi.org/10.1016/s0959-8049(01)00198-8.

APA

van Agthoven, M., Vellenga, E., Fibbe, W. E., Kingma, T., & Uyl-de Groot, C. A. (2001). Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin’s lymphoma or Hodgkin’s disease. a prospective randomised trial. European Journal of Cancer (Oxford, England : 1990), 37(14), 1781–1789. https://doi.org/10.1016/s0959-8049(01)00198-8

Chicago

van Agthoven, M, E Vellenga, W E Fibbe, T Kingma, and C A Uyl-de Groot. 2001. “Cost Analysis and Quality of Life Assessment Comparing Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation or Autologous Bone Marrow Transplantation for Refractory or Relapsed Non-Hodgkin’s Lymphoma or Hodgkin’s Disease. a Prospective Randomised Trial.” European Journal of Cancer (Oxford, England : 1990) 37 (14): 1781–89. doi:10.1016/s0959-8049(01)00198-8.